AL
ARIA

Airain Ltd’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Airain Ltd’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-88,931
Closed -$556K – 1228
2015
Q4 		$556K Buy
88,931
+45,276
+104% +$297K 0.04% 433
2015
Q3 		$255K Buy
+43,655
New +$336K 0.02% 636
2014
Q4 		– Sell
-57,246
Closed -$309K – 1039
2014
Q3 		$309K Buy
+57,246
New +$334K 0.02% 575
2014
Q1 		– Sell
-12,625
Closed -$86K – 935
2013
Q4 		$86K Buy
+12,625
New +$68.2K 0.01% 528
2013
Q3 		– Sell
-22,388
Closed -$392K – 750
2013
Q2 		$392K Buy
+22,388
New +$397K 0.06% 316

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Airain Ltd's ARIA Position: Q1 2016 in Review

Airain Ltd sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2016, closing a stake of 88,931 shares — an estimated $556K sold.

Airain Ltd first reported a position in ARIA in Q2 2013 and held it in 5 quarters. The position peaked at $556K in Q4 2015. 162 funds tracked by Wall St. Rank hold ARIA as of Q1 2016.

  • Airain Ltd reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Airain Ltd sold 88,931 Ariad Pharmaceuticals Inc shares in Q1 2016, an estimated $556K.
  • Airain Ltd first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • Airain Ltd's Ariad Pharmaceuticals Inc position peaked at $556K in Q4 2015.
  • 162 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.